Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Facet-Joint Injection Market From 2025 to 2029?

The market size for facet-joint injections has seen robust growth recently. The market is set to expand from $2.78 billion in 2024 to $2.97 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.0%. Factors contributing to the growth during the historical period include the surge in chronic back and neck pain cases, increased use of minimally invasive pain treatments, a growing elderly population experiencing spinal deterioration, improved access to image-guided injection procedures, and heightened consciousness about non-surgical pain relief alternatives.

In the coming years, the market size for facet-joint injections is projected to witness robust growth, set to reach $3.85 billion by 2029 at a Compound Annual Growth Rate (CAGR) of 6.7%. Factors contributing to this growth during the forecast period can be traced back to the surging demand for non-opioid pain management therapies, the increasing implementation of image-guided injection technologies, elevated emphasis on outpatient and day care procedures, growing utilization of regenerative injection treatments and the rise in health care investments in spine disorder remedies. Key trends in the forecast period include progress in ultrasound and fluoroscopy-guided injections, the creation of advanced drug formulations for prolonged pain alleviation, and the development of combined therapies for joint pain, innovative breakthroughs in regenerative therapies including platelet-rich plasma and stem cells, and the evolution in wearable technology for tracking after injection.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24531&type=smp

What Elements Are Contributing To Growth In The Facet-Joint Injection Market?

The increase in spinal diseases and chronic back pain cases, due to sedentary lifestyle habits and poor posture, is predicted to accelerate the expansion of the facet-joint injection market. These conditions, which negatively impact the spine over the long term, can lead to continuous pain, hindered movement, and decreased quality of life. Facet-joint injections are being sought out as a minimally disruptive solution that can alleviate pain and restore movement. These injections help manage these conditions by minimizing pain and inflammation in the spine, thus providing relief. As an example, according to Spinal Cord Inc., a US-based non-profit resource center, there were around 18,000 new spinal cord injury (SCI) cases registered annually in the United States in May 2023, with an estimated 302,000 individuals nationwide currently dealing with spinal cord injuries. Subsequently, the escalating incidence of spinal diseases and chronic back pain is contributing to the facet-joint injection market’s growth. The trend for minimally invasive medical procedures is also set to boost the facet-joint injection market’s growth. These procedures, which are often performed through small incisions or without the need for large surgical incisions, are increasingly in demand due to patient preferences for quicker recovery times and less post-operative discomfort. Facet-joint injections contribute to this growing trend, offering targeted pain relief and high diagnostic accuracy without extensive surgical processes. As an example, the American Society of Plastic Surgeons, a US-based specialty organization, reported a rise in minimally invasive cosmetic procedures from 23.7 million in 2022 to 25.4 million in 2023. Consequently, the rising preference for minimally invasive procedures is fundamentally driving the facet-joint injection market’s expansion.

Which Segments Are Detailed In The Global Facet-Joint Injection Market Report?

The facet-joint injection market covered in this report is segmented –

1) By Product Type: Corticosteroids, Local Anesthetics, Hyaluronic Acid, Other Product Types

2) By Application: Cervical Facet Joints, Thoracic Facet Joints, Lumbar Facet Joints, Facet Joint Injections

3) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users

Subsegments:

1) By Corticosteroids: Triamcinolone Acetonide, Methylprednisolone Acetate, Dexamethasone Sodium Phosphate, Betamethasone, Other Corticosteroids

2) By Local Anesthetics: Lidocaine, Bupivacaine, Ropivacaine, Prilocaine, Other Local Anesthetics

3) By Hyaluronic Acid: High Molecular Weight Hyaluronic Acid, Low Molecular Weight Hyaluronic Acid, Cross-Linked Hyaluronic Acid, Non-Cross-Linked Hyaluronic Acid

4) By Other Product Types: Platelet-Rich Plasma, Biological Agents, Combination Formulations, Other Injectables

Which Emerging Trends And Strategic Shifts Are Shaping The Facet-Joint Injection Market?

Major corporations in the facet-joint injection market are concentrating their efforts on creating innovative products like facet fusion systems to provide more enduring relief and enhance treatment results. Facet fusion systems are medical devices designed to stabilize and fuse the spine’s facet joints by encouraging bone growth between neighboring vertebrae. For example, the Aurora Spine Corporation, a medical device company based in the US, announced in March 2025 that the U.S. Food and Drug Administration (FDA) had granted 510(k) clearance for its latest product, the AEROTM Facet Fusion System. The system employs a titanium plasma spray coating to enhance osseointegration and fusion potential, accommodates various implant sizes to fit different patient anatomies, and has radiolucent instrumentation to boost intraoperative visibility. All of these characteristics work together to enhance the surgical efficiency and long-term results in treating chronic back pain arising from facet joint disorders.

Who Are The Key Contributors To Growth In The Facet-Joint Injection Market?

Major companies operating in the facet-joint injection market are Pfizer Inc., Merck & Co. Inc, AbbVie Inc., Sanofi S.A., Medtronic plc, Stryker Corporation, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Henry Schein Inc., Bausch Health Companies Inc., Zimmer Biomet Holdings Inc., Smith & Nephew plc, Dr. Reddy’s Laboratories Ltd., Arthrex Inc., Aspen Pharmacare Holdings Limited, Pacira BioSciences Inc., Bioventus Inc., Ferring Pharmaceuticals, Anika Therapeutics Inc., Symbiotec Pharmalab Pvt. Ltd.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/facet-joint-injection-global-market-report

Which Region Is Projected To Lead The Facet-Joint Injection Market By 2025?

North America was the largest region in the facet-joint injection market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the facet-joint injection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24531&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model